Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Margaret Bassendine
| Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis | 2022 |
|
Dr Stephen Todryk Emeritus Professor Margaret Bassendine Dr Simon Bridge
| Revisiting the elusive hepatitis C vaccine | 2021 |
|
Emeritus Professor Margaret Bassendine Dr Simon Bridge
| COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? | 2020 |
|
Dr Simon Bridge Emeritus Professor Margaret Bassendine
| Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis? | 2018 |
|
Emeritus Professor Margaret Bassendine Dr Soren Nielsen Dr Simon Bridge Dr Daniel Felmlee Dr David Sheridan et al. | Hepatitis C virus and atherosclerosis: A legacy after virologic cure? | 2017 |
|
Dr David Sheridan Fiona Fenwick Emeritus Professor Margaret Bassendine
| Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection | 2016 |
|
Emeritus Professor Margaret Bassendine
| MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C | 2016 |
|
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Margaret Bassendine
| Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection | 2015 |
|
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely Emeritus Professor Margaret Bassendine et al. | Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency | 2014 |
|
Dr David Sheridan Emeritus Professor Margaret Bassendine
| Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection | 2014 |
|
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Fiona Fenwick Dr R Neely et al. | Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial | 2014 |
|
Emeritus Professor Margaret Bassendine
| Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort | 2011 |
|
Emeritus Professor Margaret Bassendine Emeritus Professor Alan Murray
| INCIDENCE AND PROGNOSTIC IMPORTANCE OF JAUNDICE AFTER CARDIOPULMONARY BYPASS-SURGERY | 1983 |
|
Emeritus Professor Margaret Bassendine Emeritus Professor Alan Murray
| Effects of prednisolone/azathioprine in chronic hepatitis B viral infection | 1982 |
|
Emeritus Professor Margaret Bassendine Emeritus Professor Alan Murray Emeritus Professor Oliver James
| PROSPECTIVE-STUDY OF JAUNDICE AFTER CARDIOPULMONARY BYPASS-SURGERY | 1982 |
|